Cargando…
Ex Vivo Metrics™, a preclinical tool in new drug development
Among the challenges facing translational medicine today is the need for greater productivity and safety during the drug development process. To meet this need, practitioners of translational medicine are developing new technologies that can facilitate decision making during the early stages of drug...
Autores principales: | Curtis, C Gerald, Bilyard, Kevin, Stephenson, Hugo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2257925/ https://www.ncbi.nlm.nih.gov/pubmed/18215298 http://dx.doi.org/10.1186/1479-5876-6-5 |
Ejemplares similares
-
Ex vivo gene transfer in the years to come
por: Pap, Thomas, et al.
Publicado: (2002) -
Development of an ex vivo human-porcine respiratory model for preclinical studies
por: Perinel, Sophie, et al.
Publicado: (2017) -
Successful ex vivo expansion of mouse hematopoietic stem cells
por: Ema, Hideo
Publicado: (2019) -
Ex vivo Bone Models and Their Potential in Preclinical Evaluation
por: Cramer, E. E. A., et al.
Publicado: (2021) -
Comment on “The power metric: a new statistically robust enrichment-type metric for virtual screening applications with early recovery capability”
por: Šícho, M., et al.
Publicado: (2018)